The Oncosearch | Oncotarget

The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells Research Paper

Michael R. Booth, Laurence Booth, Jane L. Roberts, John M. Kirkwood, Paul Dent

Published Mar 30, 2026 · Vol. 17, No. 1 · pp. 78-89

Keywords: macroautophagy, ER stress, aramchol, regorafenib, BID

COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms Review

Charlotte Kuperwasser, Wafik S. El-Deiry

Published Mar 30, 2026 · Vol. 17, No. 1 · pp. 1-29

Keywords: COVID, vaccine, cancer, infection, lymphoma, leukemia, sarcoma, carcinoma

Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Correction

Steven A. Greenberg

Published Mar 20, 2026 · Vol. 17, No. 1 · pp. 57-58

Retraction: Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p Retraction

Wenkang Luan, Rubo Li, Liang Liu, Xin Ni, Yan Shi, Yun Xia, Jinlong Wang, Feng Lu, Bin Xu

Published Dec 24, 2025 · Vol. 16, No. 1 · pp. 892-892

Retraction: Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells Retraction

Giuliana Gatti, Valeria Lucini, Silvana Dugnani, Angela Calastretti, Gilberto Spadoni, Annalida Bedini, Silvia Rivara, Marco Mor, Gianfranco Canti, Francesco Scaglione, Annamaria Bevilacqua

Published Dec 5, 2025 · Vol. 16, No. 1 · pp. 874-874

Retraction: Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells Retraction

Matthew L. Fisher, Daniel Grun, Gautam Adhikary, Wen Xu, Richard L. Eckert

Published Dec 5, 2025 · Vol. 16, No. 1 · pp. 865-865

Clinical and analytical validation of MI Cancer Seek^®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper

Valeriy Domenyuk, Kasey Benson, Peggy Carter, Daniel Magee, Jian Zhang, Nitin Bhardwaj, Hongseok Tae, James Wacker, Foram Rathi, Siobhan Miick, Aastha Kohli, Joshua Carroll, Lori Cuyugan, Evelyn Perez, Wayeesha Zhang, John Collins, Patrick Kennedy, Jeremy Ellis, Adam Stark, Andrey Loskutov, Brittany Cuttone, Blake Taylor, Rebecca Feldman, Jeff Swenson, David Bryant, Robert Hahn-Lowry, Raunaq Kaushal, Jennifer R. Ribeiro, Jim Abraham, Milan Radovich, George W. Sledge, Matthew Oberley, David Spetzler

Published Aug 6, 2025 · Vol. 16, No. 1 · pp. 642-659

Keywords: companion diagnostic, molecular profiling, solid tumors, precision oncology, next-generation sequencing

Correction: Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b Correction

Elisabetta Vergani, Lorenza Di Guardo, Matteo Dugo, Sara Rigoletto, Gabrina Tragni, Roberta Ruggeri, Federica Perrone, Elena Tamborini, Annunziata Gloghini, Flavio Arienti, Barbara Vergani, Paola Deho, Loris De Cecco, Viviana Vallacchi, Paola Frati, Eriomina Shahaj, Antonello Villa, Mario Santinami, Filippo De Braud, Licia Rivoltini, Monica Rodolfo

Published Jun 10, 2025 · Vol. 16, No. 1 · pp. 443-444

Retraction: RAB22A overexpression promotes the tumor growth of melanoma Retraction

Feng Su, Yifei Chen, Shilin Zhu, Fangfang Li, Shuang Zhao, Lisa Wu, Xiang Chen, Juan Su

Published May 17, 2025 · Vol. 16, No. 1 · pp. 347-347

GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells Research Perspective

Diana Crisan, Susanne Schatz, Heidi Hainzl, Fang Zhao, Annette Paschen, Maria Crisan, Adrian Baican, Karin Scharffetter-Kochanek, Abhijit Basu

Published Mar 31, 2025 · Vol. 16, No. 1 · pp. 257-259

Keywords: BRAF melanoma resistance mechanisms, GSK3 β, BRAF mutation

Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Research Paper

Steven A. Greenberg

Published Jan 7, 2025 · Vol. 16, No. 1 · pp. 1-8

Keywords: immunotherapy, KLRG1

Retraction: Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells Retraction

Matthew L. Fisher, Daniel Grun, Gautam Adhikary, Wen Xu, Richard L. Eckert

Published Aug 23, 2024

Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival Research Paper

Saif Zaman, Fred S. Gorelick, Andrea Chrobrutskiy, Boris I. Chobrutskiy, Gary V. Desir, George Blanck

Published Jul 20, 2024 · Vol. 15, No. 1 · pp. 550-561

Keywords: RNLS, melanoma, T-cell receptor CDR3s, chemical complementarity

Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma Research Paper

Caroline Naomi Valdez, Gabriela Athziri Sánchez-Zuno, Lais Osmani, Wael Ibrahim, Anjela Galan, Antonietta Bacchiocchi, Ruth Halaban, Rajan P. Kulkarni, Insoo Kang, Richard Bucala, Thuy Tran

Published Jul 15, 2024 · Vol. 15, No. 1 · pp. 507-520

Keywords: MIF, DDT, melanoma, immune checkpoint inhibition, cancer transcriptomics

Targeting the multifaceted BRAF in cancer: New directions Research Perspective

Eamon Toye, Alexander Chehrazi-Raffle, Justin Hwang, Emmanuel S. Antonarakis

Published Jul 10, 2024 · Vol. 15, No. 1 · pp. 486-492

Keywords: BRAF, MAPK, pan-cancer, precision oncology, genomics

When does a melanoma metastasize? Implications for management Research Perspective

John F. Thompson, Gabrielle J. Williams

Published Jun 4, 2024 · Vol. 15, No. 1 · pp. 374-378

Keywords: melanoma, metastasis, time, adjuvant systemic therapy, tumor doubling time

Correction: FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma Correction

Jinhua Wang, Li Li, Shiwei Liu, Ying Zhao, Lin Wang, Guanhua Du

Published Jun 3, 2024 · Vol. 15, No. 1 · pp. 379-380

GZ17-6.02 kills PDX isolates of uveal melanoma Research Paper

Laurence Booth, Jane L. Roberts, Ivan Spasojevic, Kaitlyn C. Baker, Andrew Poklepovic, Cameron West, John M. Kirkwood, Paul Dent

Published May 9, 2024 · Vol. 15, No. 1 · pp. 328-344

Keywords: autophagy, ER stress, GZ17-6.02, doxorubicin, afatinib, neratinib

Retraction: Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma Retraction

Mohammad Krayem, Ahmad Najem, Fabrice Journe, Renato Morandini, François Sales, Ahmad Awada, Ghanem E. Ghanem

Published Apr 19, 2024 · Vol. 15, No. 1 · pp. 354-354

Correction: Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma Correction

Lucia Longhitano, Carlo Castruccio Castracani, Daniele Tibullo, Roberto Avola, Maria Viola, Giuliano Russo, Orazio Prezzavento, Agostino Marrazzo, Emanuele Amata, Michele Reibaldi, Antonio Longo, Andrea Russo, Nunziatina Laura Parrinello, Giovanni Li Volti

Published Sep 26, 2023 · Vol. 15, No. 1 · pp. 199-199

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells Research Paper

COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms Review

Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Correction

Retraction: Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p Retraction

Retraction: Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells Retraction

Retraction: Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells Retraction

Clinical and analytical validation of MI Cancer Seek^®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper

Correction: Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b Correction

Retraction: RAB22A overexpression promotes the tumor growth of melanoma Retraction

GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells Research Perspective

Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Research Paper

Retraction: Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells Retraction

Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival Research Paper

Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma Research Paper

Targeting the multifaceted BRAF in cancer: New directions Research Perspective

When does a melanoma metastasize? Implications for management Research Perspective

Correction: FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma Correction

GZ17-6.02 kills PDX isolates of uveal melanoma Research Paper

Retraction: Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma Retraction

Correction: Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma Correction

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells Research Paper

COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms Review

Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Correction

Retraction: Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p Retraction

Retraction: Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells Retraction

Retraction: Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells Retraction

Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper

Correction: Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b Correction

Retraction: RAB22A overexpression promotes the tumor growth of melanoma Retraction

GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells Research Perspective

Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Research Paper

Retraction: Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells Retraction

Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival Research Paper

Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma Research Paper

Targeting the multifaceted BRAF in cancer: New directions Research Perspective

When does a melanoma metastasize? Implications for management Research Perspective

Correction: FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma Correction

GZ17-6.02 kills PDX isolates of uveal melanoma Research Paper

Retraction: Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma Retraction

Correction: Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma Correction

Clinical and analytical validation of MI Cancer Seek^®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper